Faculty

Institution

Unit

Venue

Wei Zhou

Professor

Emory University

Affiliations

School of Medicine

Hematology / Medical Oncology

Wei Zhou is currently serving as a Hematology / Medical Oncology Professor at Emory University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Wei Zhou

Emory University

Professor

You can click a keyword to filter the displayed items

cancer research oncology cancer biology tumor biology cell biology oncogenes cancer genetics genetics medicinal research pharmacology cancer cells molecular cancer molecular biology cancer treatment cancer genomics thoracic oncology gene expression cell signaling prostate cancer cell regulation cancer care tumor targeting signal transduction molecular cell biology signaling pathways tumor suppressors enzyme inhibition rna biology genome biology anti-cancer agents genomics cellular therapy cancer growth cancer management protein science cancer imaging medical genetics genitourinary cancers drug targeting protein phosphorylation colorectal cancer molecular regulation cellular physiology oncogenic agent vascular biology pharmacotherapy cell adhesion pathway analysis cellular biology homozygous deletion clinical investigation allelic variant cytogenetics protein function angiogenesis cell cycle cell polarity cancer-focused protein-protein interactions oncoppi network biological insights potential molecular target prokaryotic rna polymerases disease gene identification biomarker target insulin signaling liver cancer therapeutic strategies early stage human breast cancer abasic sites small molecule kras gene expression profiles yeast transcriptome human transcriptomes colorectal tumorigenesis genetic instability lung cancer urology molecular genetics tumor suppressor genes prostate tumors

Notable Scholarly Works

Notable Federal Grants

Collaborators

High Per1 Expression is Associated With Stk11 Mutation and Clinical Biomarkers of Immunotherapy Resistance in Lung Adenocarcinoma. Journal of Cancer Research and Clinical Oncology (2025)

immunologybronchial neoplasmstk11 mutationcancer geneticsthoracic oncologyhigh per1 expressioncancer immunotherapymolecular diagnosticsimmunotherapy resistanceoncogeneslung cancerpathology

High Per1 Expression is Associated With Stk11 Mutation and Clinical Biomarkers of Immunotherapy Resistance in Lung Adenocarcinoma.. Journal of cancer research and clinical oncology (2025)

immunologycancer geneticsthoracic oncologyhigh per1 expressioncancer genomicscancer immunotherapymolecular diagnosticsimmunotherapy resistanceoncogenesclinical biomarkerslung cancerpathology

Uncovering the Rewired Iap-Jak Regulatory Axis as an Immune-Dependent Vulnerability of Lkb1-Mutant Lung Cancer. Nature Communications (2025)

immunologycancer geneticscancer biologyradiation oncologycell signalingcancer discoverylkb1-mutant lung canceroncogeneslung cancerimmune-dependent vulnerability

Abstract 4047: Unraveling Synergistic Therapeutic Strategies Involving Fak Inhibition and Immunotherapy Using Anti-Pd1 Antibody in Kras and Lkb1-Driven Lung Cancer. Cancer Research (2024)

Junghui KooCarol Tucker-BurdenMelissa RoyChunzi HuangWei ZhouMelissa Gilbert-RossHaian FuSuresh S. RamalingamAdam I. Marcus

tumor targetingmedicinecancer carecancer managementanti-cancer agentscancer biologycancer researchsurgical oncologycancer immunotherapycancer treatmentimmunotherapypharmacologythoracic oncologyradiation oncologyclinical researchoncologyrespiratory medicinemedicinal researchfak inhibition

Interruption of Klf5 Acetylation Promotes Pten-Deficient Prostate Cancer Progression by Reprogramming Cancer-Associated Fibroblasts. Journal of Clinical Investigation (2024)

Baotong ZhangMingcheng LiuFengyi MaiXiawei LiWenzhou WangQingqing HuangXiancai DuWeijian DingYixiang LiBenjamin G BarwickJianping Jenny NiAdeboye O OsunkoyaYuanli ChenWei ZhouSiyuan XiaJin-Tang Dong

carcinogenesisbenign prostatic hyperplasiatumor biologyurologyprostatic diseasebiomolecular engineeringgenitourinary cancerscancer-associated fibroblastsmolecular biologyoncologyoncogenesclinical investigationcancer biologyprostate cancer

Live-Cell Invasive Phenotyping Uncovers Alk2 as a Therapeutic Target in Lkb1-Mutant Lung Cancer. Cancer Research (2024)

Junghui KooChang-Soo SeongRebecca E. ParkerAmy HerreraBhakti DwivediRobert A. ArthurAshok Reddy DinasarapuHenry Richard JohnstonHenry ClaussenCarol Tucker-BurdenSuresh S. RamalingamHaian FuWei ZhouAdam I. MarcusMelissa Gilbert-Ross

tumor targetingcancer geneticscancer biologycancer researchsystems biologycancer discoverytherapeutic targetscancer genomicscancer imagingmolecular biologyoncologyoncogenescancer cellscancer treatmentlung cancertumor biologycell biology

Abstract 16: The Role of Innate and Adaptive Immunity in the Sex Bias of Lkb1-Mutant Lung Adenocarcinoma. Cancer Research (2023)

Yijian FanLenore MonterrozaRui JinXiuju LiuPeriasamy SelvarajRabindra TirouvanziamWei Zhou

cancer geneticsadaptive immunitycancer riskcancer caremolecular cancersex biasinnate immune systemcancer genomicscancer biologyhealth sciencesleukemiacancer researchcancer immunotherapytumor biologyimmunologythoracic oncologygeneticsoncologyclinical researchmedicinal research

Abstract 811: Development of a Nox-Ros Nanoinhibitor for Enhancing Response to Radiotherapy in Lung Cancer Cells While Mitigation Radiation-Induced Inflammation and Injury in the Normal Lung Tissue. Cancer Research (2023)

Lei ZhuLumeng ZhangTongrui LiuWei Ping QianWei ZhouLily Yang

tumor targetingmedicinenanomedicinenox-ros nanoinhibitorthoracic oncologyradiation oncologycancer researchcancer imagingoncologycancer treatmentlung cancer cellscancer biologynanotechnologyhealth sciencesnormal lung tissueinflammation

Data From Modulation of Bax and Mtor for Cancer Therapeutics. (2023)

Rui LiChunyong DingJun ZhangMaohua XieDongkyoo ParkYe DingGuo ChenGuojing ZhangMelissa Gilbert-RossWei ZhouAdam I. MarcusShi-Yong SunZhuo G. ChenGabriel L. SicaSuresh S. RamalingamAndrew T. MagisHaian FuFadlo R. KhuriWalter J. CurranTaofeek K. OwonikokoDong M. ShinJia ZhouXingming Deng

cancer therapeuticsoncologypharmacology

Live-Cell Invasive Phenotyping Uncovers the Alk2/Bmp6 Iron Homeostasis Pathway as a Therapeutic Vulnerability in Lkb1-Mutant Lung Cancer. bioRxiv (Cold Spring Harbor Laboratory) (2023)

Junghui KooChang-Soo SeongRebecca E. ParkerBhakti DwivediRobert A. ArthurAshok Reddy DinasarapuH. Richard JohnstonHenry ClaussenCarol Tucker-BurdenSuresh S. RamalingamHaian FuWei ZhouAdam I. MarcusMelissa Gilbert-Ross

cancer geneticsheme homeostasispathway analysiscancer genomicscancer biologyhealth sciencescancer researchcancer immunotherapylung cancertumor biologyimmunologythoracic oncologyfree radical biologyredox biologygeneticsoncologyoncogenesmedicinal researchtherapeutic vulnerability

1
2
3
4
5
19
10 / page

Wei Zhou

Professor

Emory University

Affiliations

School of Medicine

Hematology / Medical Oncology

Wei Zhou is currently serving as a Hematology / Medical Oncology Professor at Emory University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Wei Zhou

Emory University

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

High Per1 Expression is Associated With Stk11 Mutation and Clinical Biomarkers of Immunotherapy Resistance in Lung Adenocarcinoma. Journal of Cancer Research and Clinical Oncology (2025)

immunologybronchial neoplasmstk11 mutationcancer geneticsthoracic oncologyhigh per1 expressioncancer immunotherapymolecular diagnosticsimmunotherapy resistanceoncogeneslung cancerpathology

High Per1 Expression is Associated With Stk11 Mutation and Clinical Biomarkers of Immunotherapy Resistance in Lung Adenocarcinoma.. Journal of cancer research and clinical oncology (2025)

immunologycancer geneticsthoracic oncologyhigh per1 expressioncancer genomicscancer immunotherapymolecular diagnosticsimmunotherapy resistanceoncogenesclinical biomarkerslung cancerpathology

Uncovering the Rewired Iap-Jak Regulatory Axis as an Immune-Dependent Vulnerability of Lkb1-Mutant Lung Cancer. Nature Communications (2025)

immunologycancer geneticscancer biologyradiation oncologycell signalingcancer discoverylkb1-mutant lung canceroncogeneslung cancerimmune-dependent vulnerability

Abstract 4047: Unraveling Synergistic Therapeutic Strategies Involving Fak Inhibition and Immunotherapy Using Anti-Pd1 Antibody in Kras and Lkb1-Driven Lung Cancer. Cancer Research (2024)

Junghui KooCarol Tucker-BurdenMelissa RoyChunzi HuangWei ZhouMelissa Gilbert-RossHaian FuSuresh S. RamalingamAdam I. Marcus

Interruption of Klf5 Acetylation Promotes Pten-Deficient Prostate Cancer Progression by Reprogramming Cancer-Associated Fibroblasts. Journal of Clinical Investigation (2024)

Baotong ZhangMingcheng LiuFengyi MaiXiawei LiWenzhou WangQingqing HuangXiancai DuWeijian DingYixiang LiBenjamin G BarwickJianping Jenny NiAdeboye O OsunkoyaYuanli ChenWei ZhouSiyuan XiaJin-Tang Dong

Live-Cell Invasive Phenotyping Uncovers Alk2 as a Therapeutic Target in Lkb1-Mutant Lung Cancer. Cancer Research (2024)

Abstract 16: The Role of Innate and Adaptive Immunity in the Sex Bias of Lkb1-Mutant Lung Adenocarcinoma. Cancer Research (2023)

Yijian FanLenore MonterrozaRui JinXiuju LiuPeriasamy SelvarajRabindra TirouvanziamWei Zhou

Lei ZhuLumeng ZhangTongrui LiuWei Ping QianWei ZhouLily Yang

Data From Modulation of Bax and Mtor for Cancer Therapeutics. (2023)

cancer therapeuticsoncologypharmacology

Live-Cell Invasive Phenotyping Uncovers the Alk2/Bmp6 Iron Homeostasis Pathway as a Therapeutic Vulnerability in Lkb1-Mutant Lung Cancer. bioRxiv (Cold Spring Harbor Laboratory) (2023)

1
2
3
4
5
19
10 / page

Similar Faculty Members

Jonathan D Licht

Institution

University of Florida

oncology

pathology

Wael El-Rifai

Institution

University of Miami

molecular cancer

cancer biology

Erica Golemis

Institution

Temple University

oncology

cancer research

Chellappan, Srikumar

Institution

University of South Florida

cell biology

tumor biology

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Devanand Sarkar

Institution

Virginia Commonwealth University

oncology

cancer research

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

David Fenyo

Institution

New York University

health informatics

computational biology

Similar Faculty Members

Jonathan D Licht

Institution

University of Florida

oncology

pathology

Wael El-Rifai

Institution

University of Miami

molecular cancer

cancer biology

Erica Golemis

Institution

Temple University

oncology

cancer research

Chellappan, Srikumar

Institution

University of South Florida

cell biology

tumor biology

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Devanand Sarkar

Institution

Virginia Commonwealth University

oncology

cancer research

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

David Fenyo

Institution

New York University

health informatics

computational biology